Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Argenx To Raise $300 million in U.S. public offering
Argenx To Raise $300 million in U.S. public offering
Argenx To Raise $300 million in U.S. public offering
Submitted by
admin
on September 19, 2018 - 11:44am
Source:
CP Wire
News Tags:
Argenx
Headline:
Argenx To Raise $300 million in U.S. public offering
snippet:
argynx has 8 drugs in development
Partners include Abbvie, LEO Pharma, and Staten Biotech
Do Not Allow Advertisers to Use My Personal information